<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>ANTIMICROBIAL AGENTS CHEMOTHERAPY, Feb. 2010, p. 620&#226;&#8364;&#8220;626                                                                       Vol. 54,  2 <br /> 0066-4804/10/$12.00 doi:10.1128/AAC.01025-09 <br /> Copyright &#194;&#169; 2010, American Society Microbiology. Rights Reserved. <br />  <br />  <br />  <br />         Newly Identified Antibacterial Compounds Topoisomerase <br />                       Poisons African Trypanosomes&#228;&#338;&#164; <br />                                           Sonya C. Tang Theresa  Shapiro* <br />                 Division Clinical Pharmacology, Department Medicine, Johns Hopkins University School                                                Medicine, Baltimore, Maryland 21205 <br />                       Received 21 July 2009/Returned modification 24 September 2009/Accepted 6 December 2009 <br />  <br />             Human African trypanosomiasis, caused Trypanosoma brucei protozoan parasite, fatal left <br />           untreated. Current therapies antiquated, need new pharmacologic agents T. <br />           brucei targets human ortholog. Trypanosomes single mitochondrion unique <br />           mitochondrial DNA, known kinetoplast DNA (kDNA), topologically complex network contains <br />           thousands interlocking circular DNAs, termed minicircles (&#226;&#172;&#402;1 kb) maxicircles (&#226;&#172;&#402;23 kb). Replication           kDNA depends topoisomerases, enzymes catalyze reactions change DNA topology. T. brucei           unusual type IA topoisomerase dedicated kDNA metabolism. enzyme ortholog humans, <br />           RNA interference (RNAi) studies shown essential parasite survival, making ideal <br />           drug target. large <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span>chemical</span> library screen, compounds recently identified poisons bacterial <br />           topoisomerase IA. compounds trypanocidal low micromolar range           promote formation linearized minicircles covalently bound protein 5&#226;&#180;&#8226; end, consistent           poisoning mitochondrial topoisomerase IA. Surprisingly,  band depletion studies showed           topoisomerase IImt, topoisomerase IAmt, trapped. compounds planar aromatic <br />           polycyclic structures intercalate unwind DNA. findings reinforce utility topoisom- <br />           erase IImt target development new drugs African sleeping sickness. <br />  <br />  <br />    Human African trypanosomiasis, known African                     intermediates, reattachment network progeny <br /> sleeping sickness, protozoal infection caused Trypano-              minicircles, retain nicks gaps circles soma brucei fatal treatment (3). Parasites              replicated. step kDNA replication depends transmitted humans tsetse fly, exclu-             function topoisomerases. enzymes catalyze reac- <br /> sively sub-Saharan Africa limits geographic                 tions alter topological state DNA cleaving distribution disease. Currently, estimated              phosphodiester backbone formation covalent <br /> 50,000 70,000 cases (25). Despite lethality sleeping              phosphotyrosine link, transferring segments DNA sickness, drugs currently available treatment               break, ligating DNA (topoisomer- <br /> toxic require parenteral administration (10). addi-             ases reviewed references 7, 9, 28). classi- <br /> tion obstacles, resistance growing concern,             fied types, based number DNA strands availability cost major problems population             cleaved: type enzymes cleave strand type II  <br /> affected. light issues, new drugs African trypano-          zymes cleave strands reactions requiring <span id='am-5' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-6' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-7' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span>ATP</span>. Type somiasis demand. recently completed T. brucei                    enzymes classified B subfamilies based <br /> genome sequence possible identification po-                 structural mechanistic differences. Topoisomerase IA <br /> tential drug targets essential trypanosomes                                                                             enzymes catalyze relaxation negatively supercoiled DNA human ortholog (2). <br />                                                                             &#226;&#8364;&#339;enzyme bridging mechanism.&#226;&#8364;? cleavage    Trypanosomes single mitochondrion unusual <br />                                                                             single strand, topoisomerase IA remains covalently bound mitochondrial DNA, known kinetoplast DNA (kDNA).                                                                             5&#226;&#172;&#732; end processively unwinds DNA. enzyme <br /> kinetoplast massive topologically complex structure, <br />                                                                             acts preexisting nick, pass double helix <br /> comprised thousands interlocked &#226;&#172;&#402;1-kb DNA minicircles <br />                                                                             resulting double-stranded break. type II  dozen &#226;&#172;&#402;23-kb maxicircles (structure replication <br />                                                                             zymes utilize 5&#226;&#172;&#732;-end linkage catalysis, contrast kDNA reviewed reference 16). intricate network striking contrast monomeric circular DNA                     IB topoisomerases, create covalent link 3&#226;&#172;&#732; end <br /> molecule copies human mitochon-                    cleavage site. <br /> drion. Replication kDNA requires release individ-                    T. brucei catalytically active topoisomerases, ual covalently closed minicircles network                   appear function exclusively mitochondrion: <br /> pool &#226;&#8364;&#339;free&#226;&#8364;? minicircles, DNA synthesis theta structure               topoisomerase IAmt topoisomerase IImt (15, 21). mi- <br />                                                                             tochondrial enzymes especially attractive drug targets                                                                             essential according RNA interference (RNAi)   * Corresponding author. Mailing address: Johns Hopkins University         drug studies (21), depletion leads akinetoplasty <br /> School Medicine, 301 Hunterian Building, 725 North Wolfe Street, <br />                                                                              loss kDNA), turn results death (13). <br /> Baltimore, MD 21205. Phone: (410) 955-1888. Fax: (410) 955-2634. <br /> E-mail: tshapiro@jhmi.edu.                                                     Compounds target topoisomerases classified   &#228;&#338;&#164; <br />     Published ahead print 14 December 2009.                           poisons nonpoisoning inhibitors (17). Poisons bind  <br />                                                                       620 <br />  VOL. 54, 2010                                                                         ANTITRYPANOSOMAL TOPOISOMERASE POISONS                                       621 <br />  <br />                                                                                     ogies, ). Compounds 1895 0020 purchased ChemDiv (San <br />                                                                                     Diego, CA; catalog numbers 4333-1895 4711-0020, respectively), dissolved                                                                                     dimethyl sulfoxide (DMSO), aliquoted, stored &#226;&#171;&#186;20&#194;&#176;C. <br />                                                                                        Cytotoxicity assay. Compounds 1895 0020 assayed antitrypano- <br />                                                                                     somal activity using acid phosphatase-based 96 plate method (4). Briefly, <br />                                                                                     100 &#226;?&#174;l cells (2 &#226;&#171;&#187; 105/ml) incubated 100 &#226;?&#174;l medium containing <br />                                                                                     solvent 2&#226;&#171;&#187; serially diluted compound (20 24 h, 37&#194;&#176;C). concentration <br />                                                                                     assayed quadruplicate. Final DMSO concentrations did exceed 1%. <br />                                                                                     Lethality confirmed microscopic examination motility. Acid phos- <br />                                                                                     phatase activity surviving cells measured adding 20 &#226;?&#174;l buffer <br />                                                                                     containing 20 mg/ml p-nitrophenyl phosphate 1 M sodium acetate, pH 5.5, 1% <br />    FIG. 1. Molecular structure 1895  , N,N-dimethyl-2-                Triton X-100 (5 h, 37&#194;&#176;C). Absorbance measured 405 nm. compound <br /> (phenanthro[3,4-d][1,3]dioxol-5-yl)ethanamine, 0020 (B),               assayed times. Curve fitting 50% effective concentration (EC50) <br /> 2-(piperidin-1-ylmethyl)indeno[1,2,3 phthalazin-3-(2H)                 determinations obtained Emax model (12) DeltaGraph Pro 3.5. <br /> terest, 1895 contains methylenedioxy motif seen etoposide                 Based Chauvenet&#226;&#8364;&#8482;s criterion (26), values  576 total) wells semisynthetic derivatives camptothecin, topo-                 identified outliers dropped analysis. <br /> isomerase poisons.                                                                     Free minicircle profiles. concentration, 12 &#226;?&#174;l 10&#226;&#171;&#187; compound                                                                                     added 1.2 &#226;&#171;&#187; 107 cells 108 &#226;?&#174;l medium (30 min, 37&#194;&#176;C). Just lysis,                                                                                     portion taken Western blot analysis  . remaining cells <br />                                                                                     lysed equal volume 10 mM Tris HCl, pH 8.0, 75 mM Na2-EDTA, <br /> Michaelis complex comprised DNA enzyme, forming                            1% SDS, 2 mg/ml proteinase K (2 h, 55&#194;&#176;C), treated ternary DNA-protein-inhibitor &#226;&#8364;&#339;cleavable complex.&#226;&#8364;? situ,                         100 &#226;?&#174;g/ml RNase (30 min, 37&#194;&#176;C). Samples separated electrophoresis presence poison prevents strand ligation,                     1.5% agarose gels containing 89 mM Tris base, 89 mM boric acid, 2 mM <br />                                                                                     EDTA 1 &#226;?&#174;g/ml ethidium bromide (35 V, 24 h). DNA transferred topoisomerase remains inert complex fixed                      Hybond XL membrane (GE Healthcare), washed 750 mM NaCl 75 mM <br /> DNA helix. Covalent adducts topoisomerase DNA                            sodium citrate, UV cross-linked (Stratagene UV Cross-linker 1800) mem- forged rapid denaturation topoisomerase                           branes, hybridized Church-Gilbert solution 32P-labeled probe detergents sodium dodecyl sulfate (SDS). Nonspecific                        recognizes 124-bp conserved minicircle sequence (overnight, 45&#194;&#176;C) (21). <br />                                                                                     Membranes exposed PhosphorImager plate scanned (Fuji <br /> inhibitors decrease topoisomerase activity pro- <br />                                                                                     BAS 2500 PhosphorImager) visualized Image Gauge version 3.45 (Fuji <br /> mote formation cleavable complexes. include                         Photo Films Company). Unless indicated  Adobe Photoshop used <br /> agents deform DNA substrate, bind proteins high                       adjust contrast brightness  <br /> affinity, compete binding active sites, DNA                          Exonuclease treatment. Trypanosomes treated 25.5 &#226;?&#174;M 1895 ATP analogs. cell, stationary cleavable complexes                        63 &#226;?&#174;M 0020 (1 h, 37&#194;&#176;C) lysed digested proteinase K                                                                                     RNase  described  DNA extracted buffer-saturated phenol <br /> prove lethal replication machinery collides                          phenol-chloroform-isoamyl alcohol (25:24:1), followed producing breaks DNA (11, 17). Therapeutically useful                        extraction ethanol precipitation. Samples redissolved 100 &#226;?&#174;l 10 <br /> topoisomerase-targeting agents poisons: fluoroquinolo-                      mM Tris HCl, pH 8.0, 1 mM Na2-EDTA; applied QiaAmp DNA microkit <br /> nes etoposide topoisomerase II poisons antibacte-                       (Qiagen) cleanup; eluted 30 &#226;?&#174;l distilled water; treated 10 U &#226;?&#173; <br /> rial antitumor therapy, respectively, camptothecin                     exonuclease buffer containing 67 mM <span id='am-16' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-17' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span>glycine</span>-KOH, pH 9.4, 2.5 mM MgCl2, <br />                                                                                     50 &#226;?&#174;g/ml bovine serum albumin (BSA) 10 U exonuclease III buffer antitumor agent poisons topoisomerase IB. T.                            containing 10 mM Bis-Tris-propane-HCl, pH 7.0, 10 mM MgCl2, 1 mM dithio- <br /> brucei, poisons topoisomerase IAmt ideal                           threitol final volume 40 &#226;?&#174;l (30 min, 37&#194;&#176;C). HindIII-linearized pBluescript enzyme human ortholog exclu-                         (80 ng) added treatment internal control. Minicircle DNA sively mitochondrion kDNA (21).                                         separated visualized described  <br />                                                                                        Western blot band depletion. 8 &#226;&#171;&#187; 106 cells reserved lysed    Recently, luciferase reporter detects accumu- <br />                                                                                     equal volume 117 mM Tris HCl, pH 6.8, 3.4% SDS, 10% glycerol, 0.2 M <br /> lation covalent DNA complexes recombinant Yersinia                          dithiothreitol, 0.004% bromophenol blue. Proteins separated SDS- <br /> pestis topoisomerase IA Escherichia coli developed (8).                  PAGE transferred polyvinyl difluoride membranes (Millipore). Blots used high-throughput assay screen com-                       blocked 3% bovine serum albumin 25 mM Tris HCl, pH 7.4, 150 <br /> pounds poisoned Y. pestis topoisomerase IA. com-                         mM NaCl, 0.05% Tween 20, probed following primary                                                                                     secondary antibodies: anti-c-Myc (1:1,000; Santa Cruz Biotechnologies)&#226;&#8364;&#8220;anti- <br /> pounds promote intracellular cleavable complex                        rabbit-horseradish peroxidase (anti-rabbit-HRP; 1:20,000; Santa Cruz Biotech- <br /> formation recombinant topoisomerase IA inhibit                        nologies) anti-T. brucei-topoisomerase IImt (1:5,000 [15])&#226;&#8364;&#8220;anti-guinea pig- <br /> relaxation DNA isolated enzyme. compounds                           HRP (1:40,000; Sigma). Loading control provided anti-human enolase inhibited growth bacterial cells.                                       (1:200; Santa Cruz Biotechnologies)&#226;&#8364;&#8220;anti-rabbit-HRP (1:30,000). Quantitation <br />                                                                                     Image J (1). <br />    Lead compounds 1 2 identified Y. pestis model <br />                                                                                        Precipitation topoisomerase-DNA complexes. ability compounds <br /> (Fig. 1), referred 1895 0020, respectively,                     1895 0020 promote intracellular cleavable complex formation nuclear tested T. brucei assess cytotoxic activity                      DNA determined potassium-SDS (KSDS) assay (5, 27). Trypanosomes <br /> ability poison topoisomerase IAmt. compounds                          (107 cells ml) <span id='am-40' about='obo:IMR_0200384' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-41' property="rdfs:label" content="Thymidine" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasDbXref" content="KEGG:C00214" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:id" content="IMR:0200384" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>thymidine</span>-free medium radiolabeled 333 &#226;?&#174;Ci/ml trypanocidal micromolar concentrations,                         [3H]thymidine (20 Ci/mmol; Perkin-Elmer; 1 h, 37&#194;&#176;C), washed times, <br />                                                                                     resuspended 107 cells/ml, treated DMSO, 500 &#226;?&#174;M etoposide, 50 &#226;?&#174;M <br /> appear intercalate DNA,  unexpectedly, pro-                        1895, 50 &#226;?&#174;M 0020 (30 min, 37&#194;&#176;C). Samples assayed triplicate. equal <br /> mote linearization free minicircles poisoning intracellular                   volume lysis buffer (1.25% SDS, 5 mM EDTA, 0.4 mg/ml calf thymus DNA) <br /> topoisomerase IImt.                                                                 added, lysates incubated (10 min, 65&#194;&#176;C). Covalent DNA-protein <br />                                                                                     complexes precipitated addition ice-cold 65 mM KCl washed <br />                                                                                     times 10 mM Tris HCl, pH 8.0, 100 mM KCl, 1 mM EDTA, 0.1 mg/ml <br />                         MATERIALS METHODS <br />                                                                                     calf thymus DNA, radioactivity counted liquid scintillation. Total <br />   experiments performed bloodstream-form Trypanosoma brucei           incorporation radioactivity control cells measured triplicate brucei (MiTat 1.2 strain 427; doubling time, 6 8 h), containing c-Myc-tagged   aliquoting 5 &#226;&#171;&#187; 105 untreated labeled cells glass filter paper precipitating <br /> topoisomerase IA allele (21), grown 37&#194;&#176;C HMI-9 containing 10% fetal           DNA 5% ice-cold trichloroacetic acid. calculate percentage DNA <br /> bovine serum, 10% Serum Plus, 0.8 &#226;?&#174;g/ml G418 (Gibco BRL Life Technol-           trapped cleavable complexes, averaged counts minute detected  622      TANG SHAPIRO                                                                                        ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />   FIG. 2. Killing activity T. brucei vitro 1895   0020 (B). concentration tested (assayed quadruplicate), coefficients variation 10%. Data fitted equation Emax model obtain EC50s; R2 values 0.99 graphs. <br />  <br />  <br />  <br /> KSDS precipitates divided averaged counts minute trichloro-   appears decrease linear forms, rebound <br /> <span id='am-59' about='obo:IMR_0200208' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-60' property="rdfs:label" content="Acetic acid" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasDbXref" content="KEGG:C00033" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:id" content="IMR:0200208" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>acetic acid</span> precipitates.                                                        120 &#226;?&#174;M. wavering pattern observed repro- <br />    DNA unwinding. DNA unwinding 1895 0020 assayed described <br /> previously (24). brief, 250 ng supercoiled pBluescript pBluescript <br />                                                                                  ducibly experiments. <br /> relaxed Escherichia coli topoisomerase IA treated various concen-       Linear forms expected product 1895 trations 1895 0020 50 mM Tris HCl, pH 7.5, 50 mM NaCl, 5 mM        0020 poisoning topoisomerase IAmt. type enzymes <br /> MgCl2, 1 pM vaccinia virus topoisomerase IB (gift James         make single-stranded break, poisoning lead Stivers) added (1 h, 37&#194;&#176;C). Reactions quenched addition 10&#226;&#171;&#187; <br /> DNA loading dye containing 0.625% SDS, 0.125% xylene cyanol, 0.125% bro- <br />                                                                                  increase nicked, linearized, minicircles.  mophenol blue, 62.5% glycerol. DNA separated 1% agarose 89 mM          population nicked/gapped minicircles treated cells Tris base, 89 mM boric acid, 2 mM EDTA visualized ethidium bromide        comparable controls (Fig. 3B 3C). fluorescence.                                                                    topoisomerase IAmt works preexisting nick                                                                                  minicircle molecules topoisomerase IAmt work <br />                                 RESULTS                                          adjacent opposite strands, linear forms                                                                                  generated treatment compounds 1895 0020. <br />    Trypanocidal activity vitro. Increasing concentrations                                                                                     Linearized minicircles protected exonuclease di- <br /> 1895 0020 tested bloodstream T. brucei                                                                                  gestion. determine protein covalently bound <br /> assess killing activity (Fig. 2). determinations,                                                                                  5&#226;&#172;&#732; 3&#226;&#172;&#732; end cleavage sites linear forms, <br /> EC50 1895 6.3 &#226;&#171;&#190; 4.3 &#226;?&#174;M 0020 16.9 &#226;&#171;&#190; 8.8 <br />                                                                                  minicircles extracted cells treated 1895 &#226;?&#174;M. perspective, potencies trypanosomes                                                                                  0020 subjected &#226;?&#173; exonuclease, degrades linear <br /> comparable known topoisomerase poisons (<span id='am-45' about='obo:IMR_0100024' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0001355 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-46' property="oboInOwl:hasDbXref" content="KEGG:C00575" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="Adenosine 3&apos;,5&apos;-phosphate" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasAlternativeId" content="IMR:0200099" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasExactSynonym" content="Adenosine 3&apos;,5&apos;-phosphate" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="Cyclic AMP" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:id" content="IMR:0100024" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="Cyclic AMP" datatype="xsd:string"></span><span id='am-54' property="rdfs:label" content="cAMP" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="3&apos;,5&apos;-Cyclic AMP" datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="3&apos;,5&apos;-Cyclic AMP" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="Cyclic adenylic acid" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasExactSynonym" content="Cyclic adenylic acid" datatype="xsd:string"></span>camp</span>- <br />                                                                                  DNA 5&#226;&#172;&#732; end, exonuclease III, degrades <br /> tothecin, 1.5 &#226;?&#174;M [4]; ciprofloxacin, 52 &#226;?&#174;M [18]) low <br />                                                                                  3&#226;&#172;&#732; end (Fig. 4). Internal control linear pBluescript compared clinically used agents trypanosomiasis <br />                                                                                  completely digested samples containing exonuclease, ver- <br /> (pentamidine, 14 nM [4]; berenil, 94 nM [4]), difluo- <br />                                                                                  ifying enzymatic activity (Fig. 4B). Minicircle linear forms romethylornithine (&#226;&#172;&#381;147 &#226;?&#174;M [29]). <br />    Compounds 1895 0020 promote minicircle lineariza-                         cells treated compound protected deg- <br /> tion. determine antitrypanosomal activity related               radation &#226;?&#173; exonuclease exonuclease III, <br /> topoisomerase IAmt, free minicircle replication intermediates                    indicating DNA blocked protein 5&#226;&#172;&#732; end treated cells analyzed Southern hybridization (Fig.                 (Fig. 4A). finding rules topoisomerase IB mecha- <br /> 3). electrophoresed presence ethidium bro-                        nism  requires 3&#226;&#172;&#732;-phosphotyrosine link) mide, free minicircles separated nicked/gapped daugh-                   consistent topoisomerase II, protein  <br /> ter circles, linear forms, covalently closed template circles.               valently bound 5&#226;&#172;&#732; end strands.  type IA expected, etoposide, known poison T. brucei topoisom-                    enzymes bind 5&#226;&#172;&#732; end cleavage site. erase IImt (23), increased linearized minicircles concen-                   linear forms produced topoisomerase IAmt molecule <br /> tration-dependent fashion (Fig. 3A, left panel). linear                    acted preexisting nick, single strand <br /> forms substantially reduced samples treated                      DNA protected digestion &#226;?&#173; exonuclease. <br /> proteinase K, consistent covalent linkage protein                  new population minicircle DNA runs faster (Fig. 3A, right panel).                                                          covalently closed circles does appear samples digested    Compounds 1895 0020 rise increase                      &#226;?&#173; exonuclease, present control sample <br /> protease-sensitive linear forms (Fig. 3B 3C). 1895,                   treated &#226;?&#173; exonuclease. topoisomerase IAmt mole- <br /> concentrations 0 40 &#226;?&#174;M, steady increase                   cules worked close proximity opposite strands, lin- linear forms, 60 &#226;?&#174;M, population decreases                       earized forms strands protected 5&#226;&#172;&#732; end (Fig. 3B). Based proteinase K sensitivity, 80 100 &#226;?&#174;M,                  produced. linear forms protein bound. 0020, pattern                       Depletion free topoisomerase cell lysates. deter- protein-bound linear forms complicated (Fig. 3C).                     mitochondrial topoisomerase covalently linked presence proteinase K, linear forms increase steadily                  linearized minicircles, lysates treated cells analyzed 0 40 &#226;?&#174;M level 80 &#226;?&#174;M. 100 &#226;?&#174;M                      immunoblotting. method, topoisomerase enzyme <br />  VOL. 54, 2010                                                                  ANTITRYPANOSOMAL TOPOISOMERASE POISONS                             623 <br />  <br />  <br />  <br />  <br />    FIG. 3. Free minicircle profiles. T. brucei treated indicated lysed SDS buffer. Lysates digested   proteinase <br /> K, indicated, DNA separated electrophoresis prior Southern blotting minicircle DNA.   Lanes 1 4, 0, 4, 20, 100 &#226;?&#174;M <br /> etoposide, respectively (5 &#226;&#171;&#187; 106 cells/lane). (B) Lanes 1 7, 0, 10, 20, 40, 60, 80, 100 &#226;?&#174;M 1895, respectively (1.7 &#226;&#171;&#187; 106 cells/lane). (C) Lanes <br /> 1 6, 0, 20, 40, 80, 100, 120 &#226;?&#174;M 0020, respectively (1.7 &#226;&#171;&#187; 106 cells/lane). Samples treated 10 60 &#226;?&#174;M incomplete proteolysis shown. position lanes blot switched present results increasing concentrations. N/G, nicked/gapped; L, <br /> linear; CC, covalently closed. <br />  <br />  <br />                                                                              covalently bound DNA unable enter gel matrix                                                                              free topoisomerase molecules detected (14). ex- <br />                                                                              pected, etoposide treatment depletes topoisomerase IImt                                                                              effect topoisomerase IAmt (Fig. 5A 5B, left <br />                                                                              panels). Interestingly, cells treated 1895 0020,                                                                              decrease topoisomerase IAmt, indicating                                                                              compounds promote cleavable complex formation                                                                              enzyme trypanosomes (Fig. 5A, central right pan- <br />                                                                              els).  lead significant decrease free <br />                                                                              topoisomerase IImt, indicating protein respon- <br />                                                                              sible minicircle linearization (Fig. 5B, central right <br />                                                                              panels). depletion free topoisomerase IImt 1895                                                                              0020 reproducibly obtained inde- <br />                                                                              pendent experiments, respectively. effect                                                                              catalytic subunit topoisomerase IB (data shown),                                                                              enzyme acts nucleus mitochondrion                                                                              trypanosomes (5). <br />                                                                                 Nuclear topoisomerase II trapped cleavable com- <br />    FIG. 4. Exonuclease susceptibility minicircle DNA                 plexes. assess possible effect nuclear topo- <br /> treated T. brucei. Cells treated drug, 25.5 &#226;?&#174;M 1895, 63 &#226;?&#174;M 0020 indicated lysed SDS. Internal control                 isomerases, utilized KSDS assay. 95% DNA HindIII-linearized pBluescript added sample prior             trypanosomes nuclear (6), assay monitors cleavable com- <br /> exonuclease treatment.   Southern blot minicircle DNA. Lanes            plex formation nucleus. experiment, total <br /> 1, 4, 7, exonuclease. Lanes 2, 5, 8, &#226;?&#173; exonuclease. Lanes         incorporation [3H]thymidine 3.7 &#226;&#171;&#187; 105 cpm/107 cells. 3, 6, 9, exonuclease III. 2.45 &#226;&#171;&#187; 107 cells/lane. <br /> (B) Reaction internal control pBluescript DNA visualized                                                                              presence DMSO, 2.2% total DNA covalently <br /> ethidium bromide fluorescence prior DNA transfer minicircle           bound protein precipitated, attributable naturally <br /> hybridization.                                                               occurring topoisomerase catalytic complexes situ (Table 1). <br />  624       TANG SHAPIRO                                                                                          ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />    FIG. 5. Western blots T. brucei proteins treatment indicated SDS lysis.   Free topoisomerase IAmt signals enolase <br /> controls. (Left) Lanes 1 3, 0, 4, 100 &#226;?&#174;M etoposide, respectively (1 &#226;&#171;&#187; 106 cells/lane). (Center) Lanes 1 5, 0, 40, 60, 80, 100 &#226;?&#174;M 1895, <br /> respectively (8.33 &#226;&#171;&#187; 105 cells/lane). (Right) Lanes 1 5, 0, 20, 60, 100, 120 &#226;?&#174;M 0020, respectively (8.33 &#226;&#171;&#187; 105 cells/lane). far-right panel results quantitated correcting topoisomerase signal cognate enolase control normalizing treated samples untreated controls. Etoposide, filled circles; 1895, filled squares; 0020, filled triangles. (B) Free topoisomerase IImt signals enolase controls; <br /> concentrations panel  Membranes hybridized antibodies c-Myc (&#226;?&#163;-cMyc) visualize c-Myc-tagged topoisomerase IAmt, topoisomerase IImt (&#226;?&#163;-IImt), enolase (&#226;?&#163; . far-right panel, quantitation symbols given  quantitative data panels verified analysis independent investigator. <br />  <br />  <br />  expected, etoposide increased signal                         prior electrophoresis. binding intercalators fold. trypanosomes, trapping nuclear topoisomerase                        ethidium bromide causes DNA helix unwind form <br /> II apparent etoposide concentrations low 1 &#226;?&#174;M                       positive supertwists. presence topoisomerase maximal &#226;&#172;&#402;100 &#226;?&#174;M (data shown). Table 1, 500                        relaxed equilibrium, topoisomerase &#226;?&#174;M concentration utilized ensure robust positive                           intercalator subsequently removed, DNA hy- <br /> control. Interestingly, contrast etoposide, 1895                     pernegatively supercoiled. absence added compound, 0020 reduced cleavable complex formation nuclear                           vaccinia virus topoisomerase IB relaxes DNA substrates <br /> DNA, concentrations maximize linearization                           (Fig. 6A D, lanes 2).  relaxation occurs minicircles (Fig. 3 Table 1).                                                   presence ethidium bromide, isolated products hy- <br />    Compounds 1895 0020 unwind DNA. polycyclic,                              pernegatively supercoiled (Fig. 6A D, lanes 3 4). aromatic, planar structures 1895 0020 suggest                     unwinding effect seen, concentration-dependent <br /> compounds DNA intercalators. assess possibil-                        fashion, 1895 0020 DNA substrates ity, plasmid DNA incubated various concentrations                       negatively supercoiled relaxed (Fig. 6A D, lanes 5 10). <br /> 1895 0020 treated vaccinia virus topoisomerase IB, <br />                                                                                                             DISCUSSION <br />  <br />           TABLE 1. situ formation topoisomerase-DNA                              discovery essential mitochondrial topoisom- <br />                         cleavable complexes                                         erase IAmt T. brucei ortholog humans (21),                                               Cleavable complexes                   great study effects African trypano- <br />       Compounda <br />         (&#226;?&#174;M)                                                                        somes newly described antibacterial topoisomerase IA poi- <br />                                 % total DNAb                 Ratio DMSO <br />                                                                                     sons (8). compounds trypanocidal activity DMSO                               2.2 &#226;&#171;&#190; 0.05                         1.0           low micromolar concentrations. Furthermore, promoted <br /> Etoposide (500)                    9.0 &#226;&#171;&#190; 0.81                         4.2           formation covalent protein adducts minicircle <br /> 1895 (50)                          1.9 &#226;&#171;&#190; 0.09                         0.86          DNA, expected topoisomerase poisons oper- <br /> 0020 (50)                          1.7 &#226;&#171;&#190; 0.13                         0.79 <br />                                                                                     ating mitochondrion trypanosomes. Protein  <br />       compound assayed triplicate.                                        tached 5&#226;&#172;&#732; end minicircle DNA, consistent poi- <br />   b <br />     KSDS-precipitable radioactivity treated cells, percentage trichlo- <br /> roacetic acid-precipitable radioactivity untreated cells. Values means &#226;&#171;&#190;     soning type IA enzyme.  band depletion studies <br /> standard deviations.                                                                unexpectedly revealed enzyme captured  VOL. 54, 2010                                                              ANTITRYPANOSOMAL TOPOISOMERASE POISONS                                     625 <br />  <br />  <br />                                                                           tween chromosomal DNA minicircle DNA. pos- <br />                                                                           sible compounds selectively concentrated                                                                           mitochondrion. <br />                                                                              Ability intercalate DNA explain varia- <br />                                                                           tion seen reproducibly accumulation linearized <br />                                                                           minicircles function concentration 1895 0020 (Fig. <br />                                                                           3B 3C). Intercalators insert DNA bases                                                                           unwind DNA mixed effects topoisomerases. <br />                                                                           intercalators inhibit topoisomerases poison- <br />                                                                           ing  seen 4&#226;&#172;&#732;-(9-acridinylamino)-methanesul- <br />                                                                           fon-o-anisidide (o-AMSA).  closely  <br />                                                                           lated isomer m-AMSA, poison topoisomerase II, promote                                                                           formation double-stranded breaks, clinically useful <br />                                                                           antitumor agents (17, 19, 20). 2-Methyl-9-hydroxyellipticinium <br />                                                                           (2 9-OH-E&#226;&#171;&#185;), intercalator, effect similar                                                                           observe 1895 0020: low concentrations stim- <br />                                                                           ulate cleavable complex formation topoisomerase II,                                                                           higher concentrations trapping topoisomerase II  <br />                                                                           duced (19, 20). effects result distortion                                                                           substrate DNA induced strong intercalators present high <br />                                                                           ratios. intercalation effect account                                                                           decrease linearization minicircles high concentrations <br />                                                                           reduction SOS response seen high <br />                                                                           concentrations 1895 used Y. pestis model (8).                                                                           keeping intercalation effect, unwinding assay <br />    FIG. 6. DNA unwinding assay. Lanes 1 4, supercoiled relaxed      0020 appears stronger intercalator 1895, consistent <br /> plasmid DNA (lanes 1) treated topoisomerase IB (lanes      greater inhibition cleavable complex formation 2) topoisomerase IB presence 1.0 2.5 &#226;?&#174;g/ml <br /> ethidium bromide (lanes 3 4, respectively). Lanes 5 10, topo-      nuclear DNA (Table 1). <br /> isomerase IB treatment presence 500, 250, 125, 67.5, 33.8,      Compounds 1895 0020 poison mitochondrial <br /> 16.9 &#226;?&#174;M 1895, respectively  B), 310, 155, 77.5, 38.8, 19.4,   type IA topoisomerase T. brucei, despite ability 9.70 &#226;?&#174;M 0020, respectively (C D). 100 ng plasmid            poison cognate enzyme bacteria. Instead, com- <br /> DNA/lane. EtBr, ethidium bromide; IB, vaccinia virus topoisomerase <br /> IB; sc DNA, supercoiled pBluescript plasmid substrate; DNA,  <br />                                                                           pounds act mitochondrial, nuclear, topo- <br /> laxed pBluescript plasmid substrate.                                      isomerase II trypanosomes. unexpected,  <br />                                                                           ings corroborate mitochondrial topoisomerase II                                                                           suitable target development needed new  <br />                                                                           titrypanosomal drugs. <br /> trypanosome&#226;&#8364;&#8482;s mitochondrial type II, type IA, topoisom- <br /> erase. Trapping mitochondrial type II enzyme                                          ACKNOWLEDGMENTS <br /> consistent protection 5&#226;&#172;&#732; end minicircle DNA,                                                                              work supported NIH R01AI028855, National Insti- provides satisfying explanation formation pro-            tutes Health Medical Scientist Training Grant T32GM07309, tein-bound linearized, nicked, minicircles               PhRMA Foundation&#226;&#8364;&#8482;s Paul Calabresi Medical Student Research <br /> SDS lysis treated cells. Interestingly, T. brucei         Fellowship. work received Excellence Medical Student second type II topoisomerase operates nucleus,              Research award Johns Hopkins University School Medi- enzyme poisoned 1895 0020 shown              cine. <br />                                                                              thank Rahul Bakshi Jane Scocca assistance KSDS assay.                                                               methodology, helpful discussions, suggestions manuscript. <br />    trypanosomes, selective poisoning mitochondrial,             grateful Paul Englund Robert Jensen sugges- nuclear, topoisomerase II seen previously              tions, James Stivers providing vaccinia virus topoisomerase IB, number structurally unrelated DNA-binding antitrypanoso-               Jeannette Fanning administrative support. <br /> mal drugs (22). finding contrast seen                                                                                                           REFERENCES <br /> etoposide, does bind directly DNA traps                                                                            1. Abramoff, M. D., P. J. Magelhaes, S. J. Ram. 2004. Image processing <br /> nuclear mitochondrial topoisomerase II (23). planar                   Image J. Biophotonics Int. 11:36&#226;&#8364;&#8220;42. <br /> aromatic structure 1895 0020 suggested              2. Aguero, F., B. Al-Lazikani, M. Aslett, M. Berriman, F. S. Buckner, R. K. acting intercalators T. brucei lead                   Campbell, S. Carmona,  M. Carruthers,  W. Chan, F. Chen, G. J. <br />                                                                               Crowther, M.  Doyle, C. Hertz-Fowler,  L. Hopkins, G. McAllister, S. <br /> differential poisoning mitochondrion nucleus. DNA                  Nwaka, J. P. Overington,  Pain, G. V. Paolini, U. Pieper, S.  Ralph,  <br /> unwinding assays confirmed 1895 0020 DNA                     Riechers, D. S. Roos,  Sali, D. Shanmugam, T. Suzuki, W. C. Van Voorhis, <br />                                                                               C. L. Verlinde. 2008. Genomic-scale prioritization drug targets: intercalators. exact basis selective poisoning mito-               TDR Targets database. Nat. Rev. Drug Discov. 7:900&#226;&#8364;&#8220;907. <br /> chondrial nuclear type II topoisomerases DNA-                   3. Barrett, M. P., R. J. Burchmore,  Stich, J. O. Lazzari,  C. Frasch, J. J. <br /> binding agents unknown, relate intrinsic dif-                Cazzulo, S. Krishna. 2003. trypanosomiases. Lancet 362:1469&#226;&#8364;&#8220;1480. <br />                                                                            4. Bodley,  L., M. W. McGarry, T.  Shapiro. 1995. Drug cytotoxicity <br /> ferences enzymes, phylogenetically quite                 assay African trypanosomes Leishmania species. J. Infect. Dis. 172: <br /> distinct (15), marked structural differences                 1157&#226;&#8364;&#8220;1159. <br />  626       TANG SHAPIRO                                                                                                  ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  5. Bodley,  L., T.  Shap <br /> </body></html>